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Introduction
A need was identified to measure adherence levels to ART 
in a resource-poor setting and to assess the impact on 
adherence to ART of partner disclosure, partner support, 
other support and length of time between diagnosis and 
ART commencement. Research has shown that perceived 
support from a partner impacts positively on adherence.1 
Similarly, it has been shown that disclosure results in 
improved adherence.2 Furthermore, only about 50% of 
patients feel ready to commence treatment at the time of 
their human immunodeficiency virus (HIV) diagnosis.3
Method 
A retrospective case-control study was conducted by 
means of a file audit. Information from the files was excellent 
as standardised forms were used. These were completed 
thoroughly by the medical officer and included pill counts, 
which were used to measure adherence in this study. 
Random selection of files was carried out to obtain the final 
sample of 199 eligible folders. The cases were defined as 
those participants with less than 95% adherence. Each 
case was matched for age and gender with one control from 
the adherent group (at least 95% adherence). Eighty-two of 
94 participants could be matched.
An adequate sample size was calculated in consultation 
with a statistician. Standard summary statistics were used 
to summarise the data, and analysis of variance (ANOVA) 
and cross-tabulation were used to compare variables. 
Ethical approval to conduct the study was obtained from 
Stellenbosch University. 
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Results 
The mean adherence of the 199 participants was 80 %. 
There was no difference in adherence between those with a 
partner and the group without a partner. Most participants 
had disclosed their HIV status to their partner: 107 out of 
121 (88.4%) participants, with no statistically significant 
difference between the group that had disclosed and the 
group that had not.
A fair number of participants who had disclosed their status 
had received support from their partners: 67/107 (63%). 
There was no significant difference in adherence between 
the group with support from their partners and the group 
without partner support. Most participants (78%) had social 
support from other sources. Comparing the adherence of 
the group with support from other sources to the group 
without support from other sources, the difference is not 
statistically significant (P = 0.0579), but there appears 
to be a trend (Figure 1) towards better adherence being 
associated with social support other than that received from 
the partner.
About half of the patients were commenced on ART within 
one year of their HIV diagnosis. There was no statistically 
significant difference for the factor length of time between 
HIV diagnosis and ART commencement between the 
groups with adherent and nonadherent participants. 
Discussion
The differences in the results of this study compared to 
other literature might be explained by the difference in 
the methodology used. More qualitative studies on larger 
samples are recommended to enable better assessment of 
the impact of partner support and acceptance of HIV on 
adherence. 
The interesting positive trend in adherence seen in the group 
with support other than that provided by the partner might 
influence the manner in which we approach support and 
disclosure prior to commencing ART. In this setting where 
most patients are strongly encouraged to disclose their HIV 
status to their partner, it appears that it does not improve 
adherence. Ethical debate surrounding patient autonomy 
vs. the risk of injury to a third party has been rife. It seems 
appropriate to suggest that further studies will be required 
to assess the healthcare burden of delaying disclosure to a 
partner. 
The mean adherence level of 80.1% is an indication that 
more work is urgently needed to improve adherence levels 
in state-run clinics in South Africa. 
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Support from other sources
Chi-square test: P = 0.05790
Figure 1: Categorised histogram of adherence categories in the groups: 
no support from sources other than the partner (support from other 
sources: n) and support from sources other than the partner (support from 
other sources: y)
